SRDAPRTEdible Oil
Sarda Proteins Ltd — Cash Flow Statement
₹84.48
+0.00%
Sarda Proteins Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -0.11 Cr | -0.23 Cr | -0.30 Cr | 0.10 Cr | — |
| Issuance Of Debt | 0.03 Cr | 0.00 | 0.00 | 0.00 | — |
| End Cash Position | 0.03 Cr | 0.12 Cr | 0.18 Cr | 0.33 Cr | — |
| Other Cash Adjustment Outside Changein Cash | 1000.00 | 1000.00 | — | -0.02 Cr | — |
| Beginning Cash Position | 0.12 Cr | 0.18 Cr | 0.33 Cr | 0.13 Cr | — |
| Changes In Cash | -0.09 Cr | -0.07 Cr | -0.14 Cr | 0.19 Cr | — |
| Financing Cash Flow | 0.03 Cr | -1000.00 | 0.00 | -1800.00 | — |
| Interest Paid Cff | 0.00 | -1000.00 | 0.00 | -1800.00 | — |
| Net Issuance Payments Of Debt | 0.03 Cr | 0.00 | 0.00 | 0.00 | — |
| Net Short Term Debt Issuance | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Short Term Debt Issuance | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Long Term Debt Issuance | 0.03 Cr | 0.00 | 0.00 | 0.00 | — |
| Long Term Debt Issuance | 0.03 Cr | 0.00 | 0.00 | 0.00 | — |
| Investing Cash Flow | 6000.00 | 0.17 Cr | 0.16 Cr | 0.09 Cr | — |
| Interest Received Cfi | 6000.00 | 0.17 Cr | 0.16 Cr | 0.09 Cr | — |
| Net Investment Purchase And Sale | -1000.00 | 0.00 | 0.00 | 0.00 | — |
| Sale Of Investment | 0.00 | 13000.00 | 0.00 | 0.00 | — |
| Purchase Of Investment | -1000.00 | -13000.00 | 0.00 | — | — |
| Net PPE Purchase And Sale | 1000.00 | 0.00 | 0.00 | 24000.00 | — |
| Sale Of PPE | 1000.00 | 0.00 | 0.00 | 24000.00 | — |
| Capital Expenditure Reported | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Operating Cash Flow | -0.11 Cr | -0.23 Cr | -0.30 Cr | 0.10 Cr | — |
| Taxes Refund Paid | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Change In Working Capital | -0.13 Cr | -0.09 Cr | -0.15 Cr | -0.17 Cr | — |
| Change In Other Current Liabilities | -0.04 Cr | 0.00 | — | — | — |
| Change In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Change In Payable | 0.22 Cr | 0.01 Cr | -0.02 Cr | 0.01 Cr | — |
| Change In Inventory | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Change In Receivables | -0.31 Cr | -0.10 Cr | -0.14 Cr | -0.18 Cr | — |
| Other Non Cash Items | -6000.00 | -0.17 Cr | -0.16 Cr | -0.09 Cr | — |
| Depreciation And Amortization | 0.00 | 0.00 | 0.00 | 4690.00 | — |
| Gain Loss On Sale Of PPE | 1000.00 | 0.00 | 0.00 | 24080.00 | — |
| Net Income From Continuing Operations | 0.02 Cr | 0.02 Cr | 0.01 Cr | 0.35 Cr | — |
| Capital Expenditure | — | -0.13 Cr | — | — | — |
| Purchase Of PPE | — | -0.13 Cr | 0.00 | — | 0.00 |
| Gain Loss On Investment Securities | — | 13000.00 | — | — | — |
| Dividends Received Cfi | — | — | 0.00 | 0.00 | 0.00 |
| Amortization Cash Flow | — | — | 0.00 | 0.00 | 0.00 |
| Net Other Financing Charges | — | — | — | 0.02 Cr | — |
| Depreciation | — | — | — | 4690.00 | 4760.00 |
| Repayment Of Debt | — | — | — | — | 0.00 |
| Short Term Debt Payments | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Sarda Proteins Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.